Global Cord Blood (CO US): Gloomy Regulatory and Business Environment Explain Cheap Valuation
Global Cord seems to be an undervalued business, however, regulatory uncertainty, decelerating subscribers addition, and declining birth rate in...
430 Views
Global Cord Blood (CO US): Overhangs Persist; Weak Q2 Results Adds to Woe
Global Cord reported muted Q2 results with revenue and new subscribers sign-ups remaining flat sequentially, representing slower recovery. Shares...
441 Views
SCCM | Cordlife Group (CLGL SP) - 3Q21 Results Saw Uptick
3Q21 results saw an uptick: 9M21 revenue/NPAT continued to be battered by Covid- 19, slipping 5%/14% YoY, respectively to S$35.9m/S$4.3m or 65%/93%...
189 Views
Smartkarma Corporate Webinar | Cordlife: Stem Cell Banking in Asia
On 23 November, 5pm SGT, join our Corporate webinar with Cordlife group CEO Tan Poh Lan and group CFO Choo Boon Yong, speaking to Insight Provider...
533 Views
(Non-SGX Report) Cordlife Group Limited: Cash Position Underpins Share Price
Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...
37 Views